{"prompt": "['MitraClip NT System', 'Clinical Investigation Plan Version: 1.0', 'Abbott', '12-lead ECG', 'Transesophageal Echocardiography (TEE)', 'Transthoracic Echocardiography (TTE)', 'NYHA Classification', 'Six Minute Walk Test (6MWT) distance', 'Modified Rankin Scalea', 'Estimation NT Pro-BNP', 'Other scheduled follow-up visits from the date of the initial MitraClip NT procedure must be conducted.', '6.2 Schedule of Events', 'Table 4.', 'Screening/', 'Discharge', '10-D', '30-D', 'Baseline', 'Medical history', 'x', 'x', 'x', 'x', 'Physical examination of the', 'x', 'X', 'x', 'x', 'patient', 'Evaluation by Local Site Heart', 'x', 'Team', 'Weight, temperature, blood', 'x', 'x', 'x', 'x', 'pressure and heart rate', 'Concomitant cardiac', 'X', 'x', 'x', 'x', 'medications including dose and', 'reason(s) for any changes from', 'Baseline', 'CBC with differentials and', 'x', 'X', 'X', 'x', 'platelet count', 'Serum Creatinine', 'x', 'X', 'X', 'x', 'Blood Urea Nitrogen (BUN)', 'x', 'X', 'X', 'x', 'Individual patient card', 'CK and CK-MB', 'x', 'X', 'X', 'x', 'STS Mortality Risk Score for', 'x', 'x', 'x', 'x', 'mitral valve replacement', 'EuroScore Il', 'x', 'x', 'X', 'x', '12-lead ECG', 'x', 'x', 'x', 'x', 'Transesophageal', 'x', 'x', 'x', 'Echocardiography (TEE)', 'TransthoracicEchocardiography', 'x', 'x', 'x', '(TTE)', 'NYHA Classification', 'x', 'X', 'x', 'x', 'Six Minute Walk Test', 'x', 'x', 'x', 'x', '(6MWT) distance', 'Modified Rankin Scalea', 'x', 'x', 'x', 'x', 'Adverse events,', 'X', 'x', 'x', 'hospitalizations, mitral valve', 'surgery, additional', 'intervention', 'Page 43 from 61']['MitraClip NT System', 'Clinical Investigation Plan Version: 1.0', 'Abbott', 'Estimation NT Pro-BNP', 'x', 'X', 'x', 'x', '7.1 Adverse Events', 'To comply with worldwide standards and guidelines on clinical investigation adverse event reporting, the', 'Sponsor has adopted uniform and worldwide applicable standard definitions and reporting timelines to be', 'used and adhered to by the investigators.', 'The following ANTICIPATED EVENTS have been identified as possible complications of the MitraClip NT', 'procedure:', 'Table 5.', 'Allergic reaction (anesthetic,', 'contrast,', 'Hemorrhage requiring transfusion', 'Heparin, nickel alloy, latex)', 'Hypotension/hypertension', 'Aneurysm or pseudo-aneurysm', 'Infection', 'Arrhythmias', 'Lymphatic complications', 'Atrial fibrillation', 'Mesenteric ischemia', 'Atrial septal defect requiring intervention', 'Mitral stenosis', 'Arterio-venous fistula', 'Mitral valve injury', 'Bleeding', 'MitraClip', 'NT', 'erosion,', 'migration', 'or', 'Cardiac arrest', 'malposition', 'Cardiac perforation', 'MitraClip NT Device thrombosis', 'Cardiac tamponade/Pericardia Effusion', 'MitraClip', 'NT', 'System', 'component(s)', 'Chordal entanglement/rupture', 'embolization', 'Coagulopathy', 'Multi-system organ failure', 'Conversion to standard valve surgery', 'Myocardial infarction', 'Death', 'Nausea/vomiting', 'Deep venous thrombus (DVT)', 'Pain', 'Dislodgement of previously implanted', 'Peripheral ischemia', 'devices', 'Prolonged angina', 'Dizziness', 'Prolonged ventilation', 'Drug', 'reaction', 'to', 'anti-', 'Pulmonary congestion', 'platelet/anticoagulation', 'agents/contrast', 'Pulmonary thrombo-embolism', 'media', 'Renal insufficiency or failure', 'Dyskinesia', 'Respiratory failure/atelectasis/pneumonia', 'Dyspnea', 'Septicemia', 'Edema', 'Shock, Anaphylactic or Cardiogenic', 'Emboli (air, thrombus, MitraClip NT', 'Single leaflet device attachment (SLDA)', 'Device)', 'Skin injury or tissue changes due to', 'Emergency cardiac surgery', 'exposure to ionizing radiation', 'Endocarditis', 'Stroke or transient ischemic attack (TIA)', 'Esophageal irritation', 'Page 44 from 61']\n\n###\n\n", "completion": "END"}